http://www.iganbio.com/
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dyno Could Realize Up To $1.8bn Under R
In Vitro Diagnostics Acquisitions